Market cap
$70.047 M
$1.41 +1.44%
Close of 7 Aug 2026
Revenue
$400.0K
#3566 by revenue
Earnings
-$18.4M
Loss-making
Shares outstanding
49,678,561
Latest filing cover page
P/E ratio
—
Cap ÷ net income
Biotechnology: Pharmaceutical Preparations — ranked by market cap
All 501 →Where these numbers come from
Share counts and financials for iBio are taken from its own SEC filings via EDGAR — public record, not an estimate. Market cap is shares outstanding multiplied by the latest close. Last updated 9 Aug 2026. Read the methodology.